Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nascent Biotech Inc NBIO

Nascent Biotech, Inc. is a phase II clinical-stage biopharmaceutical company engaged in developing monoclonal antibodies for the treatment of various cancer types. The Company focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. It owns a... see more

Recent & Breaking News (OTCQB:NBIO)

Nascent Biotech Officers Convert Liability to Stock in the Company

GlobeNewswire June 5, 2019

Nascent Biotech Founder, Dr. Mark Glassy, Will Present at AAI Convention in San Diego

GlobeNewswire May 9, 2019

Emerging Markets Report: On a Human Level

Accesswire April 11, 2019

Nascent Biotech Moves Corporate Offices to San Diego

GlobeNewswire April 9, 2019

Nascent Biotech Receives Clearance From FDA to Begin Phase I Human Trials in Brain Cancer

GlobeNewswire December 11, 2018

Nascent Biotech Uplists to the OTC QB Markets

Filing Services Canada January 25, 2018

Nascent Biotech Announces the Completion of $1,451,000 Private Equity Raise.

Filing Services Canada November 2, 2017

Nascent Biotech Engages HRA Capital to Raise Funds

Filing Services Canada August 9, 2017

Nascent Biotech Announces IND Application Filing for Treatment of Brain Cancer

Filing Services Canada April 5, 2017

Nascent Biotech Inc Announces Its Second Quarter Results

Filing Services Canada November 11, 2016

Nascent Biotech Retires Liabilities with Non Dulutive Funding

Filing Services Canada August 11, 2016

Nascent Biotech and Hisun Announce an Exclusive License Agreement for the Development and Commercialization of Nascents Primary Asset, Pritumumab, in Mainland China.

Filing Services Canada July 18, 2016

Nascent Biotech Announces Orphan Drug Designation for Pancreatic Cancer

Filing Services Canada April 26, 2016

Nascent Biotech, Inc. Announces the Addition of Mr. Doug Karas to its Board of Directors

Filing Services Canada April 14, 2016

Nascent Biotech, Inc. Announces the Addition of Dr. Ralph Zipper to Advisory Board.

Filing Services Canada April 7, 2016

Nascent Biotech Inc Announces an Agreement Reducing Its Liabilities By $1.4 Million

Filing Services Canada September 22, 2015

Nascent Biotech Inc Announces the Retirement of Its Convertible Debt

Filing Services Canada September 17, 2015

Nascent Biotech Achieves Two Key Milestones in Development of its Novel Brain Cancer Treatment

PR Newswire August 13, 2015

Nascent Biotech, Inc. President Interviewed by the Stock Radio

Filing Services Canada August 12, 2015

Nascent Biotech, Inc. Announces 2 Additions to Scientific Advisory Board

Filing Services Canada June 18, 2015